Novel Structure Elucidation Strategy for Genetically Abnormal Fibrinogens with Incomplete Fibrinopeptide Release as Applied to Fibrinogen Schwarzach
Authors:
- Agnes HenschenAHAgnes Henschen
- Maria KehlMKMaria Kehl
- Erwin DeutschEDErwin Deutsch
- 1 January 1983
- journal article
- research article
- Published by Walter de Gruyter GmbH in Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie
- Vol. 364 (2) , 1747-1752
Abstract
A novel and simple strategy was developed for the structure elucidation of those genetically abnormal fibrinogens in which thrombin is unable to release fibrinopeptide A from the abnormal molecules. The method provides evidence for the Arg leads to Cys exchange at the C-terminus of the fibrinopeptide A sequence. The abnormal fibrinogen was mercaptolysed and then S-amino-ethylated. Upon thrombin digestion, the modified fibrinogen released new peptides, as shown by high-performance liquid chromatography. The amino-acid analysis proved that these peptides correspond to the expected fibrinopeptide A variants. It was therefore concluded that the analysed case of dysfibrinogenemia, designated Fibrinogen Schwarzach, contains an A alpha 16 Arg leads to Cys exchange in the heterozygous form.Keywords
This publication has 2 references indexed in Scilit:
- COVALENT STRUCTURE OF FIBRINOGENAnnals of the New York Academy of Sciences, 1983
- Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C‐terminal arginine→histidine substitutionBritish Journal of Haematology, 1983